ASX:IMU

Imugene Stock Earnings Reports

etoro logo Buy IMU
*Your capital is at risk
$0.300
+0 (+0%)
At Close: Nov 18, 2025

Imugene Earnings Calls

Sep 30, 2025
Release date Feb 27, 2025
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Jun 30, 2025
-$0.0942 (72.29%)
Release date Aug 26, 2025
EPS estimate -$0.340
EPS actual -$0.0942
EPS Surprise 72.29%
Revenue estimate 7M
Revenue actual 3.138M
Revenue Surprise -55.17%
Mar 30, 2025
Release date Jul 29, 2025
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Dec 31, 2024
-$0.0065 (34.70%)
Release date Feb 27, 2025
EPS estimate -$0.0100
EPS actual -$0.0065
EPS Surprise 34.70%
Revenue estimate 7M
Revenue actual 1.258M
Revenue Surprise -82.03%

Last 4 Quarters for Imugene

Below you can see how IMU.AX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Dec 31, 2024 Beat
Release date Feb 27, 2025
Price on release $0.0380
EPS estimate -$0.0100
EPS actual -$0.0065
EPS surprise 34.70%
Date Price
Feb 21, 2025 $0.0380
Feb 24, 2025 $0.0370
Feb 25, 2025 $0.0360
Feb 26, 2025 $0.0360
Feb 27, 2025 $0.0380
Feb 28, 2025 $0.0370
Mar 03, 2025 $0.0360
Mar 04, 2025 $0.0360
Mar 05, 2025 $0.0360
4 days before 0%
4 days after -5.26%
On release day -2.63%
Change in period -5.26%
Mar 30, 2025
Release date Jul 29, 2025
Price on release $0.280
EPS estimate -
EPS actual -
Date Price
Jul 23, 2025 $0.310
Jul 24, 2025 $0.280
Jul 25, 2025 $0.270
Jul 28, 2025 $0.295
Jul 29, 2025 $0.280
Jul 30, 2025 $0.280
Jul 31, 2025 $0.270
Aug 01, 2025 $0.250
Aug 04, 2025 $0.300
4 days before -9.68%
4 days after 7.14%
On release day 0%
Change in period -3.23%
Jun 30, 2025 Beat
Release date Aug 26, 2025
Price on release $0.260
EPS estimate -$0.340
EPS actual -$0.0942
EPS surprise 72.29%
Date Price
Aug 20, 2025 $0.270
Aug 21, 2025 $0.275
Aug 22, 2025 $0.285
Aug 25, 2025 $0.265
Aug 26, 2025 $0.260
Aug 27, 2025 $0.270
Aug 28, 2025 $0.280
Aug 29, 2025 $0.285
Sep 01, 2025 $0.285
4 days before -3.70%
4 days after 9.62%
On release day 3.85%
Change in period 5.56%
Sep 30, 2025
Release date Feb 27, 2025
Price on release $0.0380
EPS estimate -
EPS actual -
Date Price
Feb 21, 2025 $0.0380
Feb 24, 2025 $0.0370
Feb 25, 2025 $0.0360
Feb 26, 2025 $0.0360
Feb 27, 2025 $0.0380
Feb 28, 2025 $0.0370
Mar 03, 2025 $0.0360
Mar 04, 2025 $0.0360
Mar 05, 2025 $0.0360
4 days before 0%
4 days after -5.26%
On release day -2.63%
Change in period -5.26%

Imugene Earnings History

Earnings Calendar

FAQ

When is the earnings report for IMU.AX?
Imugene Limited (IMU.AX) has scheduled its earnings report for Feb 26, 2026 before the markets open.

What is the IMU.AX price-to-earnings (P/E) ratio?
IMU.AX P/E ratio as of Nov 18, 2025 (TTM) is -0.95.

What is the IMU.AX EPS forecast?
The forecasted EPS (Earnings Per Share) for Imugene Limited (IMU.AX) for the first fiscal quarter 2025 is $.

What are Imugene Limited's retained earnings?
On its balance sheet, Imugene Limited reported retained earnings of $0 for the latest quarter ending Sep 30, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT IMUGENE LIMITED
Imugene
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing P...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE